Research is exploring the effects of the GLP-1 microbiome on the gut and metabolism, with potential implications for treatments such as bariatric surgery and GLP-1 drugs. The gut microbiome may play a role in how individuals respond to these treatments, which are used for conditions including type 2 diabetes and weight loss. Studies are investigating the broader impact of GLP-1-based therapies on overall health, including potential effects beyond metabolic regulation.